GE HealthCare (GEHC) and Medis Medical Imaging will collaborate on developing and commercializing software for diagnosing and treating coronary artery disease (CAD).
Called Medis Quantitative Flow Ratio (Medis QFR), the software was developed by Medis and is designed to visualize the physiology of coronary obstructions based on angiography imaging. The software can help clinicians select lesions for treatment and create treatment plans for percutaneous coronary interventions to treat to restore blood flow, GE HealthCare said. In addition, the analysis can be performed in real-time while patients are on the table, with results displayed on monitors in the cath lab.
The software will be added to GE HealthCare’s interventional cardiology portfolio surrounding the Allia platform, GE HealthCare added.
